Becton Dickinson Price to Sales Ratio 2012-2026 | BDX
Historical PS ratio values for Becton Dickinson (BDX) over the last 10 years. The current P/S ratio for Becton Dickinson as of May 08, 2026 is .
| Becton Dickinson P/S Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Sales per Share | Price to Sales Ratio |
| 2026-05-08 | 149.43 | 2.00 | |
| 2026-03-31 | 157.23 | $74.77 | 2.10 |
| 2025-12-31 | 151.60 | $76.29 | 1.99 |
| 2025-09-30 | 145.42 | $75.72 | 1.92 |
| 2025-06-30 | 133.11 | $73.98 | 1.80 |
| 2025-03-31 | 175.94 | $71.99 | 2.44 |
| 2024-12-31 | 173.47 | $71.05 | 2.44 |
| 2024-09-30 | 183.48 | $69.40 | 2.64 |
| 2024-06-30 | 177.13 | $68.36 | 2.59 |
| 2024-03-31 | 186.81 | $68.11 | 2.74 |
| 2023-12-31 | 183.33 | $67.61 | 2.71 |
| 2023-09-30 | 193.59 | $67.53 | 2.87 |
| 2023-06-30 | 197.02 | $66.46 | 2.96 |
| 2023-03-31 | 184.06 | $65.67 | 2.80 |
| 2022-12-31 | 188.36 | $65.33 | 2.88 |
| 2022-09-30 | 164.44 | $65.71 | 2.50 |
| 2022-06-30 | 181.32 | $63.87 | 2.84 |
| 2022-03-31 | 190.22 | $63.50 | 3.00 |
| 2021-12-31 | 179.25 | $63.68 | 2.81 |
| 2021-09-30 | 174.60 | $65.36 | 2.67 |
| 2021-06-30 | 172.17 | $63.88 | 2.70 |
| 2021-03-31 | 171.55 | $61.62 | 2.78 |
| 2020-12-31 | 175.94 | $60.36 | 2.91 |
| 2020-09-30 | 163.04 | $57.60 | 2.83 |
| 2020-06-30 | 167.09 | $61.04 | 2.74 |
| 2020-03-31 | 159.93 | $63.37 | 2.52 |
| 2019-12-31 | 188.68 | $63.45 | 2.97 |
| 2019-09-30 | 174.96 | $63.25 | 2.77 |
| 2019-06-30 | 173.79 | $63.21 | 2.75 |
| 2019-03-31 | 171.66 | $62.97 | 2.73 |
| 2018-12-31 | 154.40 | $63.22 | 2.44 |
| 2018-09-30 | 178.28 | $61.44 | 2.90 |
| 2018-06-30 | 163.16 | $58.96 | 2.77 |
| 2018-03-31 | 147.11 | $57.09 | 2.58 |
| 2017-12-31 | 144.82 | $54.93 | 2.64 |
| 2017-09-30 | 132.12 | $54.96 | 2.40 |
| 2017-06-30 | 131.07 | $55.65 | 2.36 |
| 2017-03-31 | 122.76 | $56.62 | 2.17 |
| 2016-12-31 | 110.35 | $57.15 | 1.93 |
| 2016-09-30 | 119.27 | $57.54 | 2.07 |
| 2016-06-30 | 112.12 | $57.43 | 1.95 |
| 2016-03-31 | 99.98 | $57.23 | 1.75 |
| 2015-12-31 | 101.03 | $53.33 | 1.89 |
| 2015-09-30 | 86.60 | $49.93 | 1.73 |
| 2015-06-30 | 92.07 | $46.32 | 1.99 |
| 2015-03-31 | 92.93 | $42.76 | 2.17 |
| 2014-12-31 | 89.70 | $42.99 | 2.09 |
| 2014-09-30 | 73.04 | $42.75 | 1.71 |
| 2014-06-30 | 75.57 | $42.16 | 1.79 |
| 2014-03-31 | 74.45 | $41.54 | 1.79 |
| 2013-12-31 | 69.93 | $41.14 | 1.70 |
| 2013-09-30 | 62.98 | $40.49 | 1.56 |
| 2013-06-30 | 61.92 | $39.35 | 1.57 |
| 2013-03-31 | 59.60 | $38.66 | 1.54 |
| 2012-12-31 | 48.47 | $37.76 | 1.28 |
| 2012-09-30 | 48.39 | $36.66 | 1.32 |
| 2012-06-30 | 45.77 | $35.51 | 1.29 |
| 2012-03-31 | 47.25 | $34.60 | 1.37 |
| 2011-12-31 | 45.20 | $33.93 | 1.33 |
| 2011-09-30 | 44.08 | $33.42 | 1.32 |
| 2011-06-30 | 51.54 | $31.93 | 1.61 |
| 2011-03-31 | 47.39 | $30.88 | 1.53 |
| 2010-12-31 | 50.05 | $29.83 | 1.68 |
| 2010-09-30 | 43.66 | $29.61 | 1.47 |
| 2010-06-30 | 39.63 | $29.83 | 1.33 |
| 2010-03-31 | 45.89 | $29.55 | 1.55 |
| 2009-12-31 | 45.75 | $29.10 | 1.57 |
| 2009-09-30 | 40.27 | $28.33 | 1.42 |
| 2009-06-30 | 40.98 | $27.66 | 1.48 |
| 2009-03-31 | 38.45 | $27.60 | 1.39 |
| 2008-12-31 | 38.91 | $27.49 | 1.42 |
| 2008-09-30 | 45.42 | $27.31 | 1.66 |
| 2008-06-30 | 45.85 | $27.18 | 1.69 |
| 2008-03-31 | 48.26 | $26.25 | 1.84 |
| 2007-12-31 | 46.83 | $25.52 | 1.83 |
| 2007-09-30 | 45.81 | $24.67 | 1.86 |
| 2007-06-30 | 41.47 | $24.20 | 1.71 |
| 2007-03-31 | 42.66 | $23.49 | 1.82 |
| 2006-12-31 | 38.79 | $22.82 | 1.70 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical & Dental Supplies | $43.913B | $21.840B |
| Becton, Dickinson and Company, is a medical technology company engaged principally in the development, manufacture and sale of medical devices, instrument systems and reagents. BD's operations consisted of three business segments: BD Medical, BD Diagnostics and BD Biosciences. The company's organizational structure was realigned to form two principal business segments: BD Medical, BD Life Sciences and BD Interventional. BD Medical: BD Medical's major product lines include needles, syringes and intravenous catheters for medication delivery and generic prefilled injectables. BD Life Sciences - BD Diagnostics provides products for the safe collection and transport of diagnostics specimens to detect a broad range of infectious diseases, healthcare-associated infections and cancer. BD Biosciences produces research and clinical tools that facilitate the study of cells to gain a better understanding of normal and disease processes. With the acquisition of C.R. Bard, BD added a new segment - BD Interventional. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| McKesson (MCK) | United States | $106.025B | 23.03 |
| Cardinal Health (CAH) | United States | $50.715B | 22.43 |
| West Pharmaceutical Services (WST) | United States | $18.493B | 35.19 |
| Straumann Holding AG (SAUHY) | Switzerland | $16.902B | 0.00 |
| Cooper (COO) | United States | $13.894B | 16.52 |
| Align Technology (ALGN) | United States | $12.400B | 21.09 |
| Henry Schein (HSIC) | United States | $8.645B | 15.16 |
| Merit Medical Systems (MMSI) | United States | $4.072B | 19.84 |
| DENTSPLY SIRONA (XRAY) | United States | $2.339B | 7.36 |
| STAAR Surgical (STAA) | United States | $1.309B | 0.00 |
| CONMED (CNMD) | United States | $1.107B | 7.97 |
| Pro-Dex (PDEX) | United States | $0.165B | 19.65 |
| Lifevantage (LFVN) | United States | $0.053B | 5.46 |
| Axe Compute (AGPU) | United States | $0.022B | 0.00 |